ALEENA KHAN: Open Payments
NPI 1508457912 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 31 payments from 20 companies in 2025. Trend: 2023 $4,836 · 2024 $4,399 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $201 |
| GlaxoSmithKline, LLC. | 6 | $169 |
| Syndax Pharmaceuticals, Inc. | 1 | $82 |
| Merck Sharp & Dohme LLC | 2 | $63 |
| Spectrum Pharmaceuticals Inc. | 1 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $31 |
| Karyopharm Therapeutics Inc. | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| Celgene Corporation | 2 | $30 |
Products named: JEMPERLI, KEYTRUDA, OPDIVO, ENHERTU, ROLVEDON, ERLEADA, XPOVIO, ULTOMIRIS.
Industry payments across CA — which companies pay providers there.
